In April of 2020 the Food And Drug Administration (FDA) issued a voluntary recall on all Zantac (sometimes called Ranitidine) products after discovering high levels of cancer-causing carcinogens in the drug.
Zantac is a popular over-the-counter heartburn medication. Prolonged use of Zantac and other generic drugs containing Ranitidine can increase the levels of N-Nitrosodimethylamine (NDMA), a cancer-causing carcinogen, within the human body over time. NDMA is known to cause cancers in the stomach, esophagus, bladder, prostate, breasts, kidneys, thyroid and other areas of the body.
Though levels of NDMA discovered by FDA labs were statistically significant and deemed “unacceptable.” An independent study done by Stanford University showed that the levels of NDMA excreted through urine increased 400% in those who were asked to take Ranitidine-based products like Zantac. This study also noted that since much of the NMDA was metabolized by the body before excretion, the systemic exposure to NDMA may actually be much higher. Additional studies show that a long shelf-storage period can increase levels of NDMA found in Zantac and other similar products.
Since April, 2020, Ranitidine-based drugs have been pulled from all pharmaceutical shelves and are no longer being manufactured by drug companies in the United States. Other countries, including Canada, France, and the United Kingdom, have also recalled the drug.
Lowe Eklund Wakefield strongly supports the FDA recall of Zantac and other Ranitidine-based acid reflux and heartburn drugs sold in the United States. As a personal injury law firm, LEW works tirelessly to bring justice and peace of mind to those affected by irresponsible pharmaceutical companies that place their customers in danger by exposing them to harmful drugs. We believe these drug manufacturers must be held accountable for their actions.
“As we have for all of our clients for the last several decades, we will work tirelessly to ensure that individuals who have suffered injury due to ingestion of Zantac receive appropriate compensation from the drug companies for injuries caused to them by this dangerous drug,” said Ryan Fisher, partner attorney at Lowe Eklund Wakefield.
Lowe Eklund Wakefield is currently representing a number of clients diagnosed with cancer after taking Zantac products. If you’ve developed cancer after taking ranitidine, our firm may be able to help deliver justice to you and your family.
For more information about Lowe Eklund Wakefield, please visit our website or Contact Us today for a free legal consultation.